Agentic AI in Healthcare: $450B Marketing Opportunity by 2028

Agentic AI in healthcare is moving beyond prompt-based assistance to autonomous execution across life sciences marketing workflows. According to a report cited by Capgemini Invent, AI agents could generate up to $450 billion in economic value globally by 2028 through revenue uplift and cost savings. The study also finds that 69% of executives plan to deploy agents in marketing processes by the end of the year, signaling that agentic transformation is becoming central to commercial strategy. 

In pharmaceutical marketing, reduced face-time between sales representatives and healthcare professionals (HCPs) has intensified the need for smarter engagement. However, fragmented CRM, events, and claims data often prevent reps from accessing critical intelligence before meetings. Capgemini Invent’s Briggs Davidson argues that agentic AI in healthcare addresses this gap by autonomously querying, synthesizing, and acting on unified data across systems. 

Unlike conversational AI, agentic systems execute multi-step workflows. For example, an AI agent can identify oncologists with lower prescription volumes who attended recent congresses, generate HCP intelligence briefs, analyze prescribing behavior, and recommend personalized outreach channels. The system can then create tailored call plans and suggest next-best actions under human oversight. 

Key capabilities depend on “AI-ready data,” defined as standardized, accessible, complete, and trustworthy information. This enables: 

• Faster decision-making through predictive alerts 

• Personalization at scale across thousands of HCPs 

• Measurable marketing ROI linked to prescription outcomes 

The report stresses that successful implementation requires marketing–IT alignment, KPI definition, workflow redesign, and governance guardrails. Regulatory complexity, including compliance with healthcare data standards, remains a critical consideration. 

By 2028, the scale of value created by agentic AI in healthcare will depend not only on technology maturity, but on data integration, compliance readiness, and enterprise operating model transformation. 

 

Source: 

https://www.artificialintelligence-news.com/news/agentic-ai-healthcare-pharma-marketing-450b-value-2028/